- United States
- /
- Interactive Media and Services
- /
- NasdaqGS:GOOGL
Cloud AI Update - Transforming Unstructured Data Integration with AI-Driven Solutions
Reviewed by Simply Wall St
In a significant advancement for the Cloud AI sector, Ataccama has announced the integration of its data trust platform, Ataccama ONE, with Snowflake Marketplace, now featuring Document AI capabilities. This integration allows organizations to efficiently transform unstructured data—such as documents and contracts—into structured data, thus enhancing the value and reliability of AI-driven analytics. With unstructured data constituting a majority of enterprise information and presenting substantial governance challenges, the ability to structure and monitor this data within the Snowflake environment addresses critical operational needs. This development underlines the growing importance of effectively managing unstructured data in the age of AI, ensuring trustworthy analytics and better-informed business decisions.
- Snowflake (NYSE:SNOW) last closed at $210.10 up 0.2%, not far from its 52-week high.
Elsewhere in the market, Nebius Group (NasdaqGS:NBIS) was a standout up 17.5% and finishing the session at $46.30. Meanwhile, CoreWeave (NasdaqGS:CRWV) lagged, down 17.2% to end the day at $135.05. On Wednesday, CoreWeave, in collaboration with NVIDIA and IBM, delivered a record-breaking MLPerf Training v5.0 submission demonstrating their cloud platform's superior AI workload performance.
Best Cloud AI Stocks
- Microsoft (NasdaqGS:MSFT) ended the day at $467.68 up 0.8%, hovering around its 52-week high. Three days ago, the company, in partnership with ConnectWise and Pax8, announced a new integrated solution to enhance IT services for MSPs.
- Alphabet (NasdaqGS:GOOGL) finished flat at, $168.21.
- Apple (NasdaqGS:AAPL) finished trading at $200.63 down 1.1%.
Taking Advantage
- Jump into our full catalog of 163 Cloud AI Stocks, which includes NS Solutions, Juniper Networks and EPAM Systems, here.
- Curious About Other Options? AI is about to change healthcare. These 22 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Sources:
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NasdaqGS:GOOGL
Alphabet
Offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America.
Outstanding track record with excellent balance sheet.
Similar Companies
Market Insights
Community Narratives

